Business · 31/05/2006Updated: 10/17/2026 · 1 min read
FDA Approves New Dosage Form for Trimethoprim and Sulfadiazine Animal Drugs
Summary
The FDA has amended its regulations to reflect the approval of a supplemental new animal drug application for Schering-Plough Animal Health Corp.'s trimethoprim and sulfadiazine injectable suspension, used to treat horses as a systemic antibacterial.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →